Freya Meds review

What it is

Freya Meds Inc., which also appears in its terms as Freya Meds International Inc., is a telehealth company that started in Australia under the name Trim and moved its business to the U.S. It describes itself as a non-clinical administrative and technology service for independent, state-licensed professional corporations, whose providers do the prescribing. The team listed on its site includes co-founder Bonnie McMahon, a former GLP-1 patient; lead dietitian Adalyn White; lead clinician Sienna Steckel, a nurse practitioner; and consulting physician Christopher Findley. It sells two products, compounded semaglutide and compounded tirzepatide, and claims more than 450,000 patients. Its terms say it can't serve Alabama, Mississippi or West Virginia, and disputes go to individual arbitration in Wyoming. Insurance, Medicare and Medicaid aren't accepted.

How it works

You start with a two-minute quiz covering height, weight, goal weight, health conditions and medications. A U.S.-licensed provider reviews it and, if you qualify, confirms a prescription, often the same day. You choose semaglutide or tirzepatide, and the medication ships as a monthly supply, with free shipping the site describes as about three days. The main promise is that you work with one clinician throughout, who reviews your results before each refill or dose change. The site describes check-ins at about two, four and eight weeks, followed by ongoing monitoring, plus unlimited messaging for questions about dosing and side effects. Each plan also includes a one-on-one session with a dietitian and monthly live group calls. If you're switching from another provider, list your current dose on the intake form so your clinician can start you at the right point. Support requests go through a contact form.

Pricing transparency

Freya's product pages give the clearest prices. Compounded semaglutide is $297 a month on a monthly plan or $250 a month billed and delivered quarterly. Compounded tirzepatide is $390 a month on a monthly plan or $332 a month quarterly. Each includes the medication, syringes, unlimited clinician consultations, monthly group calls, a dietitian consultation and free shipping. Because you pay for a monthly treatment plan rather than a specific vial, dose increases are built in at no extra cost, so the price stays the same as you titrate. The home page and FAQ quote lower starting figures, from $150 a month for semaglutide and $249 for tirzepatide, and the quiz page runs a countdown banner about bundle savings, so the price at checkout may differ from either set of numbers; confirm it before paying. There are no membership fees. Freya says there's no lock-in and you can cancel any time, but it doesn't publish a refund policy or say what happens to a quarterly plan you cancel partway through. HSA and FSA aren't mentioned, and insurance isn't accepted.

Branded vs compounded

Freya prescribes compounded semaglutide and compounded tirzepatide as weekly injections, described as personalized formulations. Its terms say compounded drugs are made by licensed pharmacies for individual patients and are not reviewed or approved by the FDA, and that medication from its partner pharmacy network ships without child-resistant packaging. You can also choose your own pharmacy. It doesn't name the compounding pharmacy. The 15% and 20% average weight-loss figures on the site come from the clinical trials of the brand-name drugs, not from Freya's patients. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered, and there's no oral option. The site displays a LegitScript seal. A search of the FDA warning-letter database under the company's name and web address returned no letters.

Pros and watch-outs

The evidence behind what Freya Meds prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How Freya Meds compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Live Vital

  Pairing a GLP-1 with a wider peptide and longevity protocol

  See Live Vital →
• Trimi Health

  Low-cost compounded GLP-1 with thorough dosing guidance

  See Trimi Health →
• Cora Health

  Cash buyers who want an all-inclusive compounded GLP-1 price that doesn't rise with the dose, and who like knowing which pharmacy fills it

  See Cora Health →

More GLP-1 telehealth reviews: Alan Meds · Aspen · Better U · Big Easy Weight Loss · Boston Medical Group · Care Clinics